Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Observations on clotting activity during pre-eclampsia.

C D Lox, M M Dorsett, R M Hampton

    Clinical and Experimental Hypertension. Part B, Hypertension in Pregnancy
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of the circulating fraction of the HER-2/neu oncogene in patients with cervical cancer.

    European journal of gynaecological oncology·2003
    Same author

    Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.

    Contraception·2001
    Same author

    Improved blood substitute: evaluation of its effects on human endothelial cells.

    ASAIO journal (American Society for Artificial Internal Organs : 1992)·1998
    Same author

    Modified hemoglobin solution, with desired pharmacological properties, does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells.

    Artificial cells, blood substitutes, and immobilization biotechnology·1997
    Same author

    Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions.

    Artificial cells, blood substitutes, and immobilization biotechnology·1997
    Same author

    The effects of propranolol hydrochloride singularly or in conjunction with ethanol on clotting activity in the rat.

    General pharmacology·1996
    Same journal

    Propranolol in pregnancy three year prospective study.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    Same journal

    Renal histology and pregnancy performance in systemic lupus erythematosus.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    Same journal

    Urine dopamine during normotensive and hypertensive pregnancies and the puerperium.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    Same journal

    Pre-eclampsia in a second pregnancy.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    Same journal

    The relationship between posture and plasma catecholamines in the pregnant woman.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    Same journal

    The effect of essential fatty acid and specific vitamin supplements on vascular sensitivity in the mid-trimester of human pregnancy.

    Clinical and experimental hypertension. Part B, Hypertension in pregnancy·1983
    See all related articles

    Pre-eclampsia significantly alters blood clotting in pregnant individuals, generally increasing the activity of many clotting factors, particularly in the common pathway. This study investigated these changes in clotting factor levels during pregnancy.

    Area of Science:

    • Obstetrics and Gynecology
    • Hematology
    • Pathophysiology of Pregnancy

    Background:

    • Pre-eclampsia is a serious pregnancy complication characterized by high blood pressure.
    • Coagulation system alterations are observed in pre-eclampsia, but specific factor changes require further elucidation.

    Purpose of the Study:

    • To investigate the impact of pre-eclampsia on various blood clotting factor activities.
    • To identify specific clotting factors and pathways affected by pre-eclampsia during pregnancy.

    Main Methods:

    • Patient recruitment: Pregnant individuals with documented pre-eclampsia.
    • Measurements: Assessed prothrombin time (PT), partial thromboplastin time (APTT), fibrinogen (FIB), and clotting factors II, V, VII, VIII, X, XII, and platelet counts.
    • Analysis: Statistical comparison with normal pregnant controls.

    Related Experiment Videos

    Main Results:

    • Significant alterations in the activity of numerous clotting factors were observed in pre-eclampsia patients compared to controls.
    • Elevated clotting factor activities were a general finding, predominantly impacting the common pathway of the coagulation cascade.
    • Specific factors showing changes included those involved in the intrinsic, extrinsic, and common pathways.

    Conclusions:

    • Pre-eclampsia is associated with a pro-coagulant state, indicated by elevated clotting factor activities.
    • The common pathway of coagulation appears particularly affected in pre-eclampsia.
    • These findings contribute to understanding the hemostatic changes during pre-eclampsia.